Jim Wu, founder of SaniMed and Chairman of BioTech, participated in the University of Houston Bauer College of Business SURE Program Impact Forum. He discussed empowering startups and promoting sustainable community development with Dr. Rana Dajani and local leaders, highlighting the role of innovation in strengthening Houston’s economy and fostering social responsibility.

Torskal SAS, a French oncology innovator developing non-ionizing plasmonic PTT for cancers, has partnered with Houston-based SaniMed as its fundraising and strategic business consultant for US and international markets. SaniMed’s expertise in life science investments and commercialization will drive Torskal’s expansion and clinical development. The alliance accelerates breakthrough treatment advancements.

SaniMed Science Group offers U.S. high school and college students unique internships in medical innovation, business, and finance. Interns gain real-world experience, expert mentorship, and global exposure while enhancing leadership, communication, and professional skills—preparing them for competitive careers in the healthcare and tech-driven business sectors.

The “Harvard Autism Science and Family Forum” was held in Boston in April 2025. Jim Wu, Chairman of BioTech (Shanghai) and GHIF President, announced that starting in 2026, GHIF will co-host this annual event during World Autism Awareness Day. The forum will focus on autism research, clinical care, family support, and talent showcases, featuring experts and individuals with autism.

SaniMed Science Group launches a 30-second TV ad in Houston, highlighting its role in empowering MedTech innovation and startup growth.